Safety, efficacy and pharmacokinetics of palivizumab in off-label neonates, infants, and young children at risk for serious respiratory syncytial virus infection: a multicenter phase II clinical trial

Autor: Mori, Masaaki, Yoshizaki, Kanako, Watabe, Shinichi, Ishige, Mika, Hinoki, Akinari, Kondo, Takuya, Taguchi, Tomoaki, Hasegawa, Hisaya, Hatata, Tomoko, Tanuma, Naoyuki, Kirino, Kosuke, Hirakawa, Akihiro, Naruto, Takuya, Imai, Minoru, Koike, Ryuji, Hosoi, Kenichiro, Kusuda, Satoshi
Zdroj: In The Lancet Regional Health - Western Pacific October 2023 39
Databáze: ScienceDirect